miR-339-3p was reported to inactivate the Akt/mammalian target of rapamycin (mTOR) signaling pathway and to alleviate inflammation and edema caused by severe acute pancreatitis with acute lung injury in a mouse model by targeting annexin A3 (ANXA3) [26]. This evidence concerns the gene MTOR and acute pancreatitis.